X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs SANOFI INDIA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD SANOFI INDIA WYETH LTD/
SANOFI INDIA
 
P/E (TTM) x 27.7 33.4 83.0% View Chart
P/BV x 5.3 6.4 84.1% View Chart
Dividend Yield % 1.3 1.4 89.8%  

Financials

 WYETH LTD   SANOFI INDIA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
SANOFI INDIA
Dec-16
WYETH LTD/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,0444,560 22.9%   
Low Rs8184,400 18.6%   
Sales per share (Unadj.) Rs298.61,028.5 29.0%  
Earnings per share (Unadj.) Rs57.2129.0 44.4%  
Cash flow per share (Unadj.) Rs58.4186.0 31.4%  
Dividends per share (Unadj.) Rs17.0068.00 25.0%  
Dividend yield (eoy) %1.81.5 120.3%  
Book value per share (Unadj.) Rs249.5753.6 33.1%  
Shares outstanding (eoy) m22.7223.03 98.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.14.4 71.6%   
Avg P/E ratio x16.334.7 46.8%  
P/CF ratio (eoy) x15.924.1 66.2%  
Price / Book Value ratio x3.75.9 62.8%  
Dividend payout %29.752.7 56.3%   
Avg Mkt Cap Rs m21,157103,174 20.5%   
No. of employees `0000.53.6 13.6%   
Total wages/salary Rs m4003,592 11.1%   
Avg. sales/employee Rs Th13,787.46,537.7 210.9%   
Avg. wages/employee Rs Th813.0991.4 82.0%   
Avg. net profit/employee Rs Th2,643.3819.8 322.4%   
INCOME DATA
Net Sales Rs m6,78323,686 28.6%  
Other income Rs m353708 49.8%   
Total revenues Rs m7,13624,394 29.3%   
Gross profit Rs m1,6175,281 30.6%  
Depreciation Rs m271,313 2.0%   
Interest Rs m615 36.7%   
Profit before tax Rs m1,9384,661 41.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6321,691 37.4%   
Profit after tax Rs m1,3012,970 43.8%  
Gross profit margin %23.822.3 106.9%  
Effective tax rate %32.636.3 89.9%   
Net profit margin %19.212.5 152.9%  
BALANCE SHEET DATA
Current assets Rs m6,98415,673 44.6%   
Current liabilities Rs m2,0566,678 30.8%   
Net working cap to sales %72.638.0 191.3%  
Current ratio x3.42.3 144.7%  
Inventory Days Days9976 130.6%  
Debtors Days Days2422 107.3%  
Net fixed assets Rs m2448,098 3.0%   
Share capital Rs m227230 98.7%   
"Free" reserves Rs m5,44117,088 31.8%   
Net worth Rs m5,66817,356 32.7%   
Long term debt Rs m250-   
Total assets Rs m7,90125,400 31.1%  
Interest coverage x353.3311.7 113.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.9 92.1%   
Return on assets %16.511.8 140.7%  
Return on equity %22.917.1 134.1%  
Return on capital %34.026.9 126.4%  
Exports to sales %0.224.5 0.9%   
Imports to sales %36.328.0 129.9%   
Exports (fob) Rs m155,801 0.3%   
Imports (cif) Rs m2,4656,627 37.2%   
Fx inflow Rs m157,145 0.2%   
Fx outflow Rs m2,6776,846 39.1%   
Net fx Rs m-2,662299 -890.3%   
CASH FLOW
From Operations Rs m9233,226 28.6%  
From Investments Rs m317-1,555 -20.4%  
From Financial Activity Rs m-481-1,818 26.5%  
Net Cashflow Rs m759-147 -516.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 60.4 84.6%  
Indian inst/Mut Fund % 11.3 14.4 78.5%  
FIIs % 7.2 14.6 49.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 10.5 289.5%  
Shareholders   21,978 15,184 144.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   PLETHICO PHARMA  BIOCON LTD  FULFORD INDIA  ALKEM LABORATORIES  AJANTA PHARMA  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Firm; Software & FMCG Stocks Gain(Closing)

Indian share markets finished the trading session well above the dotted line, snapping a three-day falling streak amid firm Asian markets.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS